Tear-derived extracellular vesicles as diagnostic biomarkers for ocular and neurodegenerative diseases: opportunities and challenges

Abstract

In recent years, the prevalence of ocular diseases has increased considerably. However, timely diagnosis and treatment are hampered by the challenge of early detection since symptoms often appear in advanced stages. Emerging research highlights extracellular vesicles (EVs) as potential biomarkers for ocular diseases, with tear-derived EVs offering a minimally invasive source for early diagnosis. Tears play a crucial role in maintaining eye health and reflect the physiological state of the eye; thus, abnormalities in tear composition can provide valuable insight into inflammatory eye diseases. Studies have demonstrated the utility of tear-derived EVs in identifying biomarkers not only for inflammatory eye diseases but also for neurodegenerative disorders, as they carry molecular signatures (including proteins and various RNA species) reflective of their cells of origin. In this review, we discuss the potential of tear-derived EVs as biomarkers for early detection and monitoring of ocular and neurodegenerative diseases and highlight the importance of standardizing tear collection and EV isolation protocols to ensure reproducibility.

Keywords

Ocular diseases / neurodegenerative diseases / extracellular vesicles / tears / biomarkers

References

[1] World Health Organization. Blindness and vision impairment. World Health Organization (Geneva, Switzerland), August 10, 2023. Available from https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment [accessed 28 September 2025].

[2] Fricke TR,Resnikoff S.Global prevalence of presbyopia and vision impairment from uncorrected presbyopia: systematic review, meta-analysis, and modelling.Ophthalmology2018;125:1492-9

[3] Beykin G,Srinivasan VJ,Goldberg JL.Discovery and clinical translation of novel glaucoma biomarkers.Prog Retin Eye Res2021;80:100875 PMCID:PMC7796965

[4] Lin KY,Lin YB,Chang TJ.Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy.J Diabetes Investig2021;12:1322-5 PMCID:PMC8354492

[5] Bhedasgaonkar S.Extent of glaucomatous damage on the first presentation.Oman J Ophthalmol2023;16:227-32 PMCID:PMC10433068

[6] Schwartz R.Early detection of age related macular degeneration: current status.Int J Retina Vitreous2015;1:20 PMCID:PMC5088451

[7] Krishnadas R.The many challenges in automated glaucoma diagnosis based on fundus imaging.Indian J Ophthalmol2021;69:2566-7 PMCID:PMC8597437

[8] Tan O,Li Y.Prospective evaluation of optical coherence tomography for disease detection in the Casey mobile eye clinic.Exp Biol Med2021;246:2214-21 PMCID:PMC8718254

[9] Cicinelli MV,Khanna RC.Comprehensive eye care - issues, challenges, and way forward.Indian J Ophthalmol2020;68:316-23 PMCID:PMC7003576

[10] Niel G, Carter DRF, Clayton A, Lambert DW, Raposo G, Vader P. Challenges and directions in studying cell-cell communication by extracellular vesicles.Nat Rev Mol Cell Biol2022;23:369-82

[11] Momen-Heravi F,Alian S.Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles.Front Physiol2012;3:162 PMCID:PMC3362089

[12] Posa A,Schicht M,Beileke S.Schirmer strip vs. capillary tube method: non-invasive methods of obtaining proteins from tear fluid.Ann Anat2013;195:137-42

[13] Ravishankar P.Tears as the next diagnostic biofluid: a comparative study between ocular fluid and blood.Applied Sciences2022;12:2884

[14] Torok Z,Csosz E.Tear fluid proteomics multimarkers for diabetic retinopathy screening.BMC Ophthalmol2013;13:40 PMCID:PMC3770351

[15] Rehman I,Patel BC.Anatomy, head and neck, eye. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.

[16] Shiju TM.Extracellular vesicle biomarkers in ocular fluids associated with ophthalmic diseases.Exp Eye Res2024;241:109831

[17] Bishop PN.Structural macromolecules and supramolecular organisation of the vitreous gel.Prog Retin Eye Res2000;19:323-44

[18] Angi M,Coupland SE,Semeraro F.Proteomic analyses of the vitreous humour.Mediators Inflamm2012;2012:148039 PMCID:PMC3437669

[19] Zong Y,Hui YN.Vitreous function and intervention of it with vitrectomy and other modalities.Int J Ophthalmol2022;15:857-67 PMCID:PMC9203484

[20] Koss MJ,Nguyen N.Proteomics of vitreous humor of patients with exudative age-related macular degeneration.PLoS One2014;9:e96895 PMCID:PMC4020801

[21] Hiller JK,Rootwelt H.Metabolomic biomarkers in vitreous humor: unveiling the molecular landscape of diabetic retinopathy progression.Int J Retina Vitreous2025;11:58 PMCID:PMC12096489

[22] Yu M,Liu X.Proteomic study of aqueous humor and its application in the treatment of neovascular glaucoma.Front Mol Biosci2020;7:587677 PMCID:PMC7580691

[23] Buffault J,Hamard P,Baudouin C.The trabecular meshwork: Structure, function and clinical implications. A review of the literature.J Fr Ophtalmol2020;43:e217-30

[24] Kaeslin MA,Fuhrer CA,Huber AR.Changes to the aqueous humor proteome during glaucoma.PLoS One2016;11:e0165314 PMCID:PMC5082887

[25] Fernández-Vega Cueto A,García M.Candidate glaucoma biomarkers: from proteins to metabolites, and the pitfalls to clinical applications.Biology2021;10:763 PMCID:PMC8389649

[26] Huang K,Nguy T.Proteomics approach identifies aqueous humor biomarkers in retinal diseases.Commun Med2025;5:134 PMCID:PMC12022036

[27] Jin Y,Zhang X.Stage-dependent proteomic alterations in aqueous humor of diabetic retinopathy patients based on data-independent acquisition and parallel reaction monitoring.J Transl Med2025;23:476 PMCID:PMC12032686

[28] Khanna RK,Emond P,Blasco H.Metabolomics and lipidomics approaches in human tears: a systematic review.Surv Ophthalmol2022;67:1229-43

[29] Sheppard JD.Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape.ophthalmol ther2023;12:1397-418 PMCID:PMC10164226

[30] Zhou L.The power of tears: how tear proteomics research could revolutionize the clinic.Expert Rev Proteomics2017;14:189-91

[31] Aluru SV,Srinivasan B.Lacrimal proline rich 4 (LPRR4) protein in the tear fluid is a potential biomarker of dry eye syndrome.PLoS One2012;7:e51979 PMCID:PMC3525644

[32] Bao J,Meng Y.Total IgE in tears accurately reflects the severity and predicts the prognosis of seasonal allergic conjunctivitis.Clin Transl Allergy2022;12:e12139 PMCID:PMC8967263

[33] Liu J,Jiang Y.Roles of exosomes in ocular diseases.Int J Nanomedicine2020;15:10519-38 PMCID:PMC7778680

[34] Kapnisis K,Ross Ethier C.Modeling aqueous humor collection from the human eye.J Biomech2009;42:2454-7

[35] Fan Z,Chen L.Multiplatform tear proteomic profiling reveals novel non-invasive biomarkers for diabetic retinopathy.Eye2024;38:1509-17 PMCID:PMC11126564

[36] Ponzini E,De Palma A,Tavazzi S.Mass spectrometry-based tear proteomics for noninvasive biomarker discovery.Mass Spectrom Rev2022;41:842-60 PMCID:PMC9543345

[37] Colombo M,Théry C.Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles.Annu Rev Cell Dev Biol2014;30:255-89

[38] Yáñez-Mó M,Andreu Z.Biological properties of extracellular vesicles and their physiological functions.J Extracell Vesicles2015;4:27066 PMCID:PMC4433489

[39] Welsh JA,O’Driscoll L.MISEV ConsortiumMinimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches.J Extracell Vesicles2024;13:e12404 PMCID:PMC10850029

[40] Radeghieri A.The biomolecular corona of extracellular nanoparticles holds new promises for advancing clinical molecular diagnostics.Expert Rev Mol Diagn2023;23:471-4

[41] García-Bernal D,Yáñez RM.The current status of mesenchymal stromal cells: controversies, unresolved issues and some promising solutions to improve their therapeutic efficacy.Front Cell Dev Biol2021;9:650664 PMCID:PMC8007911

[42] Elliott RO.Unlocking the power of exosomes for crossing biological barriers in drug delivery.Pharmaceutics2021;13:122 PMCID:PMC7835896

[43] Fais S,Borras FE.Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine.ACS Nano2016;10:3886-99

[44] Habibi A,Falamarzi K.Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: a narrative review of the literature.Front Immunol2023;14:1097456 PMCID:PMC10033955

[45] Haeringen NJ. Clinical biochemistry of tears.Surv Ophthalmol1981;26:84-96

[46] Anitua E,Tayebba A.Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies.Acta Ophthalmol2015;93:e605-14

[47] Zhou L,Koh SK.In-depth analysis of the human tear proteome.J Proteomics2012;75:3877-85

[48] Tham ML,Abdullah M.Tear samples for protein extraction: comparative analysis of schirmer’s test strip and microcapillary tube methods.Cureus2023;15:e50972 PMCID:PMC10800704

[49] Fu R,Heur M,Hamm-Alvarez SF.Tear proteases and protease inhibitors: potential biomarkers and disease drivers in ocular surface disease.Eye Contact Lens2020;46 Suppl 2:S70-83 PMCID:PMC6992486

[50] Inubushi S,Mizumoto S.Oncogenic miRNAs identified in tear exosomes from metastatic breast cancer patients.Anticancer Res2020;40:3091-6

[51] Dartt DA.Complexity of the tear film: importance in homeostasis and dysfunction during disease.Exp Eye Res2013;117:1-3 PMCID:PMC4225770

[52] Janssen PT.Origin and biosynthesis of human tear fluid proteins.Invest Ophthalmol Vis Sci1983;24:623-30

[53] Zhou L.Tear analysis in ocular surface diseases.Prog Retin Eye Res2012;31:527-50

[54] Ohashi Y,Tsubota K.Laboratory findings in tear fluid analysis.Clin Chim Acta2006;369:17-28

[55] Ghaffariyeh A,Shakiba Y.Brain-derived neurotrophic factor in patients with normal-tension glaucoma.Optometry2009;80:635-8

[56] Thun Und Hohenstein-Blaul N, Funke S, Grus FH. Tears as a source of biomarkers for ocular and systemic diseases.Exp Eye Res2013;117:126-37

[57] Matheis N,Breitenfeld M.Proteomics differentiate between thyroid-associated orbitopathy and dry eye syndrome.Invest Ophthalmol Vis Sci2015;56:2649-56

[58] Aass C,Eriksen EF,Pepaj M.Single unit filter-aided method for fast proteomic analysis of tear fluid.Anal Biochem2015;480:1-5

[59] Winiarczyk M,Winiarczyk S,Winiarczyk D.Tear film proteome in age-related macular degeneration.Graefes Arch Clin Exp Ophthalmol2018;256:1127-39 PMCID:PMC5956098

[60] Eshaq RS,Alexander JS.Diabetic retinopathy: breaking the barrier.Pathophysiology2017;24:229-41 PMCID:PMC5711541

[61] Soria J,Merayo-LLoves J.Tear proteome analysis in ocular surface diseases using label-free LC-MS/MS and multiplexed-microarray biomarker validation.Sci Rep2017;7:17478 PMCID:PMC5727318

[62] Burgos-Blasco B,Santiago JL.Hypercytokinemia in COVID-19: tear cytokine profile in hospitalized COVID-19 patients.Exp Eye Res2020;200:108253 PMCID:PMC7493729

[63] Holly FJ,Esquivel ED.Kinetics of capillary tear flow in the Schirmer strip.Curr Eye Res1982;2:57-70

[64] Witwer KW,Bemis LT.Standardization of sample collection, isolation and analysis methods in extracellular vesicle research.J Extracell Vesicles2013;2 PMCID:PMC3760646

[65] Bruszel B,Janáky T.Sources of variance in human tear proteomic samples: statistical evaluation, quality control, normalization, and biological insight.Int J Mol Sci2024;25:1559 PMCID:PMC10855525

[66] Gijs M,van de Sande N.Pre-analytical sample handling effects on tear fluid protein levels.Sci Rep2023;13:1317 PMCID:PMC9873914

[67] Sitaramamma T,Rao GN.Effect of storage on protein concentration of tear samples.Curr Eye Res1998;17:1027-35

[68] Chiang JCB,Goldstein D.The impact of post-tear collection storage on tear film substance P concentration.Curr Eye Res2022;47:1116-20

[69] Brott NR,Ronquillo Y.Schirmer Test. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.

[70] Clos-Sansalvador M,Roura S,Borràs FE.Commonly used methods for extracellular vesicles’ enrichment: implications in downstream analyses and use.Eur J Cell Biol2022;101:151227

[71] Abels ER.Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake.Cell Mol Neurobiol2016;36:301-12 PMCID:PMC5546313

[72] Konoshenko MY,Vlassov AV.Isolation of extracellular vesicles: general methodologies and latest trends.Biomed Res Int2018;2018:8545347 PMCID:PMC5831698

[73] Lobb RJ,Wen SW.Optimized exosome isolation protocol for cell culture supernatant and human plasma.J Extracell Vesicles2015;4:27031 PMCID:PMC4507751

[74] Amorim M,Caramelo F.Putative biomarkers in tears for diabetic retinopathy diagnosis.Front Med2022;9:873483 PMCID:PMC9174990

[75] Shi TT,Xin Z.Tear-derived exosomal biomarkers of Graves’ ophthalmopathy.Front Immunol2022;13:1088606 PMCID:PMC9763563

[76] Grubisic Z,Benoit H.A universal calibration for gel permeation chromatography.J Polym Sci B Polym Lett1967;5:753-9

[77] Aqrawi LA,Vestad B.Identification of potential saliva and tear biomarkers in primary Sjögren’s syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.Arthritis Res Ther2017;19:14 PMCID:PMC5264463

[78] Aqrawi LA,Guerreiro EM.Proteomic and histopathological characterisation of sicca subjects and primary Sjögren’s syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.Arthritis Res Ther2019;21:181 PMCID:PMC6670195

[79] Gelibter S,Mandelli A.The impact of storage on extracellular vesicles: a systematic study.J Extracell Vesicles2022;11:e12162 PMCID:PMC8804350

[80] Théry C,Aikawa E.Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.J Extracell Vesicles2018;7:1535750 PMCID:PMC6322352

[81] Asif M,Rahman UA.Incidence of glaucoma in type 2 diabetes patients treated with GLP-1 receptor agonists: a systematic review and meta-analysis.Endocrinol Diabetes Metab2025;8:e70059 PMCID:PMC12163345

[82] Craig JP,Akpek EK.TFOS DEWS II definition and classification report.Ocul Surf2017;15:276-83

[83] Dai X,Xi M.Critical factors driving diabetic retinopathy pathogenesis and a promising interventional strategy.Biomed Pharmacother2025;189:118106

[84] Grigor’eva AE,Eremina AV.Characteristics of exosomes andmicroparticles discovered in human tears.Biomed Khim2016;62:99-106

[85] Manai F,Kaarniranta K,Amadio M.Extracellular vesicles in degenerative retinal diseases: a new therapeutic paradigm.J Control Release2024;365:448-68

[86] Rossi C,Cufaro MC.Multi-omics approach for studying tears in treatment-naïve glaucoma patients.Int J Mol Sci2019;20:4029 PMCID:PMC6721157

[87] Pucker AD,Postnikoff CK,Nichols JJ.Tear film miRNAs and their association with human dry eye disease.Curr Eye Res2022;47:1479-87 PMCID:PMC9762462

[88] Cross T,Brusletto BS.RNA profiles of tear fluid extracellular vesicles in patients with dry eye-related symptoms.Int J Mol Sci2023;24:15390 PMCID:PMC10607363

[89] Hu L,Ma H.Discovering the secret of diseases by incorporated tear exosomes analysis via rapid-isolation system: iTEARS.ACS Nano2022;16:11720-32

[90] Pieragostino D,Fasanella V.Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapy.Mol Biosyst2013;9:1108-16

[91] Dinarello CA.Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process.Am J Clin Nutr2006;83:447S-55S

[92] Xiao J.Roles of noncoding RNAs in diabetic retinopathy: mechanisms and therapeutic implications.Life Sci2024;357:123092

[93] Suire S,Anderson KE.GPCR activation of Ras and PI3Kc in neutrophils depends on PLCb2/b3 and the RasGEF RasGRP4.EMBO J2012;31:3118-29 PMCID:PMC3400018

[94] Bresciani E,Squillace N.miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir.Front Pharmacol2019;10:461 PMCID:PMC6524698

[95] Hagan S,Enríquez-de-Salamanca A.Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.EPMA J2016;7:15 PMCID:PMC4942926

[96] Kaštelan S,Pjevač N.Tear biomarkers and Alzheimer’s disease.Int J Mol Sci2023;24:13429 PMCID:PMC10488148

[97] Pieragostino D,Cicalini I.Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis.J Proteomics2019;204:103403

[98] Salvisberg C,Hainard A,Lalive PH.Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.Proteomics Clin Appl2014;8:185-94

[99] Boehm N,Wiegand M,Pfeiffer N.Alterations in the tear proteome of dry eye patients - a matter of the clinical phenotype.Invest Ophthalmol Vis Sci2013;54:2385-92

[100] Lee S,Moon CE.Amplified fluorogenic immunoassay for early diagnosis and monitoring of Alzheimer’s disease from tear fluid.Nat Commun2023;14:8153 PMCID:PMC10710446

[101] Schneider F,Metz I.Mutual functional dependence of cyclase-associated protein 1 (CAP1) and cofilin1 in neuronal actin dynamics and growth cone function.Prog Neurobiol2021;202:102050

[102] Zhong J,Liu W.Discovery of novel markers for identifying cognitive decline using neuron-derived exosomes.Front Aging Neurosci2021;13:696944 PMCID:PMC8427802

[103] Boerger M,Leha A.Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson’s disease - a pilot study.Parkinsonism Relat Disord2019;63:3-9

[104] Park HY, Kim JH, Lee KM, Park CK. Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and cornea.Exp Eye Res2012;94:13-21

[105] Bugara K,Smedowski A.Molecular pathways in experimental glaucoma models.Front Neurosci2024;18:1363170 PMCID:PMC10982327

[106] Mallone F,Marenco M.Understanding drivers of ocular fibrosis: current and future therapeutic perspectives.Int J Mol Sci2021;22:11748 PMCID:PMC8584003

[107] Fotovat-Ahmadi N,Ong J.The ocular surface tear film as a biomarker for systemic health.Ocul Surf2025;37:283-300 PMCID:PMC12129656

[108] Sampani K,Tuz-Zahra F.Neurodegenerative biomarkers in different chambers of the eye relative to plasma: an agreement validation study.Alzheimers Res Ther2024;16:192 PMCID:PMC11346268

[109] Tamhane M,Abelian G.Review of biomarkers in ocular matrices: challenges and opportunities.Pharm Res2019;36:40 PMCID:PMC6344398

[110] Su Y,Xu W,Fan X.Advances in extracellular-vesicles-based diagnostic and therapeutic approaches for ocular diseases.ACS Nano2024;18:22793-828 PMCID:PMC11363148

[111] Phan N,Yang M.Tear fluid derived extracellular vesicles for new biomarker discovery.Ocul Surf2025;37:314-22 PMCID:PMC12208681

[112] Wen K,Li Y.The effect of age on aqueous humor of humans with high myopia. Mol Vis 2024;30:137-49.

[113] Metayer C,Nguyen AM.Interest of regular assays of aqueous humor interleukin-10 levels in monitoring of vitreoretinal lymphoma.Retina2024;44:1807-13

[114] Asakage M,Komatsu H.Comprehensive microRNA analyses using vitreous humor of ocular sarcoidosis.Graefes Arch Clin Exp Ophthalmol2025;263:501-26 PMCID:PMC11868165

[115] Balikov DA,Elner VM,Rao RC.Posterior uveitis in ocular-involving chronic lymphocytic leukemia and the utility of negative MYD88 L265P testing in the diagnosis.Ocul Oncol Pathol2024;10:103-13 PMCID:PMC11178345

[116] Rentka A,Harsfalvi J.Evaluation of commonly used tear sampling methods and their relevance in subsequent biochemical analysis.Ann Clin Biochem2017;54:521-9

[117] López-Guerrero JA,Borrás FE,Vicent MJ.Standardising the preanalytical reporting of biospecimens to improve reproducibility in extracellular vesicle research - a GEIVEX study.J Extracell Biol2023;2:e76 PMCID:PMC11080825